MARKET QUARTER MEDICAL PRACTICE — All Prescriptions & Medications
Practice Code: M84050 | RUGBY, CV21 3HX
Over the last 12 months, MARKET QUARTER MEDICAL PRACTICE prescribed 147,624 items across 562 different medications at a total cost of £1,354,753 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Linaclotide | 10 | 476 | £607 | -45.3% ▼ |
| Almotriptan | 10 | 60 | £130 | -19.3% ▼ |
| Felbamate | 10 | 840 | £8.9K | -24.5% ▼ |
| Primidone | 10 | 1,238 | £1.2K | -71.9% ▼ |
| Dexamethasone phosphate | 10 | 150 | £270 | +119.2% ▲ |
| Testosterone esters | 10 | 15 | £35 | -32.2% ▼ |
| Metronidazole | 10 | 400 | £41 | +51.2% ▲ |
| Cod liver oil | 10 | 300 | £31 | -20.9% ▼ |
| Timolol and travoprost | 10 | 25 | £95 | -69.1% ▼ |
| Chlorhexidine gluconate | 10 | 4,480 | £32 | -54.5% ▼ |
| Fluocinolone acetonide | 10 | 420 | £67 | -8.2% ▼ |
| Clindamycin/tretinoin | 10 | 330 | £125 | -14.8% ▼ |
| Clindamycin phosphate | 10 | 510 | £82 | -39.2% ▼ |
| Aciclovir | 10 | 94 | £90 | -18.9% ▼ |
| 10 | 390 | £967 | -51.2% ▼ | |
| Minoxidil | 11 | 660 | £259 | -1.3% vs avg |
| Valsartan | 11 | 308 | £81 | -81.3% ▼ |
| Ipratropium bromide | 11 | 241 | £110 | -61.7% ▼ |
| Riluzole | 11 | 840 | £3.9K | +6.0% ▲ |
| Ryeqo | 11 | 308 | £753 | +95.4% ▲ |
| Levonorgestrel | 11 | 11 | £968 | -70.9% ▼ |
| Vardenafil | 11 | 84 | £129 | -21.2% ▼ |
| Magnesium glycerophosphate | 11 | 5,040 | £974 | -19.9% ▼ |
| Erythromycin | 11 | 720 | £343 | -19.0% ▼ |
| 11 | 330 | £515 | +32.6% ▲ | |
| 11 | 810 | £2.8K | +1.1% vs avg | |
| Co-tenidone (Atenolol/chlortalidone) | 12 | 672 | £29 | -42.5% ▼ |
| Telmisartan with diuretic | 12 | 588 | £212 | +6.1% ▲ |
| Diphenhydramine hydrochloride | 12 | 350 | £88 | -7.6% ▼ |
| Phenobarbital | 12 | 672 | £20 | -61.0% ▼ |
| Potassium chloride | 12 | 1,260 | £731 | -35.8% ▼ |
| Sodium chloride | 12 | 1,200 | £107 | -49.3% ▼ |
| Pyridoxine hydrochloride | 12 | 672 | £289 | -44.2% ▼ |
| Ready to serve 1.5 kcal/ml smoothie (0913021) | 12 | 36.0K | £908 | +91.9% ▲ |
| RtS 1.5 kcal/ml m/sk higher protein, higher energy (0913061) | 12 | 282.0K | £6.5K | +73.1% ▲ |
| Olopatadine | 12 | 75 | £69 | -72.6% ▼ |
| Cyclopentolate hydrochloride | 12 | 240 | £388 | +109.8% ▲ |
| 12 | 54 | £193 | -32.4% ▼ | |
| 12 | 24 | £389 | +56.9% ▲ | |
| 12 | 45 | £739 | -8.2% ▼ | |
| 12 | 140 | £360 | +2.0% ▲ | |
| 12 | 70 | £193 | -50.4% ▼ | |
| 12 | 530 | £106 | -62.2% ▼ | |
| 12 | 1,440 | £4.1K | -18.9% ▼ | |
| Olmesartan medoxomil | 13 | 364 | £13 | -81.1% ▼ |
| Acrivastine | 13 | 1,152 | £338 | +5.5% ▲ |
| Safinamide | 13 | 364 | £797 | -35.5% ▼ |
| Co-beneldopa (Benserazide/levodopa) | 13 | 1,300 | £129 | -91.4% ▼ |
| Vancomycin hydrochloride | 13 | 520 | £2.6K | +380.1% ▲ |
| Repaglinide | 13 | 2,184 | £171 | -46.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.